INS and diabetic cardiomyopathy: Altogether these findings show that in diabetic STZ mice, O304 ameliorated hyperglycemia by stimulating insulin independent glucose uptake and utilization, mitigated glycogen accumulation, and reverted diabetic cardiomyopathy.